Works by Boye, Kristina S.

Results: 84

Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines.

Published in:

European Journal of Health Economics, 2020, v. 21, n. 8, p. 1245, doi. 10.1007/s10198-020-01195-8

By:

Kennedy-Martin, Matthew;
Slaap, Bernhard;
Herdman, Michael;
van Reenen, Mandy;
Kennedy-Martin, Tessa;
Greiner, Wolfgang;
Busschbach, Jan;
Boye, Kristina S.

Publication type:

Article

The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation.

Published in:

2016

By:

Matza, Louis;
Boye, Kristina;
Feeny, David;
Bowman, Lee;
Johnston, Joseph;
Stewart, Katie;
McDaniel, Kelly;
Jordan, Jessica;
Matza, Louis S;
Boye, Kristina S;
Feeny, David H;
Johnston, Joseph A;
Stewart, Katie D

Publication type:

journal article

The real-world observational prospective study of health outcomes with dulaglutide and liraglutide in type 2 diabetes patients (TROPHIES): resource use and costs of treatment in clinical practice in France, Germany, and Italy.

Published in:

Journal of Medical Economics, 2024, v. 27, n. 1, p. 866, doi. 10.1080/13696998.2024.2367919

By:

Barrett, Annabel;
Boye, Kristina S.;
García-Pérez, Luis-Emilio;
Giorgino, Francesco;
Guerci, Bruno;
Füchtenbusch, Martin;
Yu, Maria;
Sapin, Hélène;
Dib, Anne;
Heitmann, Elke;
Federici, Marco Orsini;
Lebrec, Jérémie

Publication type:

Article

Health state utilities associated with weight loss: preferences of people with type 2 diabetes and obesity in Japan.

Published in:

Journal of Medical Economics, 2024, v. 27, n. 1, p. 370, doi. 10.1080/13696998.2024.2316400

By:

Matza, Louis S.;
Stewart, Katie D.;
Redig, Josefine;
Howell, Timothy A.;
Morris, Walter;
Newson, Rachel S.;
Yasui, Alexander;
Ishak, Jack;
Boye, Kristina S.

Publication type:

Article

The PRIME Type 2 Diabetes Model: a novel, patient-level model for estimating long-term clinical and cost outcomes in patients with type 2 diabetes mellitus.

Published in:

Journal of Medical Economics, 2022, v. 25, n. 1, p. 393, doi. 10.1080/13696998.2022.2035132

By:

Pollock, Richard F.;
Norrbacka, Kirsi;
Boye, Kristina S.;
Osumili, Beatrice;
Valentine, William J.

Publication type:

Article

Health state utilities associated with weight loss in type 2 diabetes and obesity.

Published in:

Journal of Medical Economics, 2022, v. 25, n. 1, p. 14, doi. 10.1080/13696998.2021.2002062

By:

Boye, Kristina S.;
Matza, Louis S.;
Stewart, Katie D.;
Andrews, Haylee;
Howell, Timothy A.;
Stefanski, Adam;
Malley, Karen G.;
Ishak, K. Jack;
Fernández Landó, Laura

Publication type:

Article

Patient preferences and health state utilities associated with dulaglutide and semaglutide injection devices among patients with type 2 diabetes in Italy.

Published in:

2019

By:

Boye, Kristina S.;
Matza, Louis S.;
Stewart, Katie D.;
Jordan, Jessica;
Biricolti, Giovanni;
Del Santo, Silvia;
Perez-Nieves, Magaly;
Federici, Marco O.;
Gentilella, Raffaella;
Losi, Serena;
Norrbacka, Kirsi

Publication type:

journal article

The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes.

Published in:

2019

By:

Lage, Maureen J.;
Boye, Kristina S.;
Bae, Jay Patrick;
Wu, Jianmin;
Mody, Reema;
Botros, Fady T.

Publication type:

journal article

Prevalence of complications and co‐morbidities in males and females with obesity: Real‐world insights from claims data analysis.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5005, doi. 10.1111/dom.15914

By:

Bae, Jay P.;
Nelson, David R.;
Boye, Kristina S.;
Mather, Kieren J.

Publication type:

Article

The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Final patient‐reported outcomes at 24 months.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3453, doi. 10.1111/dom.15145

By:

Boye, Kristina S.;
Lebrec, Jérémie;
Dib, Anne;
Heitmann, Elke;
Federici, Marco Orsini;
Yu, Maria;
Sapin, Hélène;
Barrett, Annabel;
Guerci, Bruno;
Giorgino, Francesco;
Füchtenbusch, Martin;
García‐Pérez, Luis‐Emilio

Publication type:

Article

Cover Image, Volume 22, Issue 3.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 1, doi. 10.1111/dom.13999

By:

Matza, Louis S.;
Boye, Kristina S.;
Stewart, Katie D.;
Coyne, Karin S.;
Wullenweber, Paula K.;
Cutts, Katelyn N.;
Jordan, Jessica B.;
Wang, Qianqian;
Yu, Maria;
Currie, Brooke M.;
Malley, Karen G.;
Ishak, K. Jack;
Hietpas, Ryan T.;
García‐Pérez, Luis‐Emilio

Publication type:

Article

Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER).

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 355, doi. 10.1111/dom.13902

By:

Matza, Louis S.;
Boye, Kristina S.;
Stewart, Katie D.;
Coyne, Karin S.;
Wullenweber, Paula K.;
Cutts, Katelyn N.;
Jordan, Jessica B.;
Wang, Qianqian;
Yu, Maria;
Currie, Brooke M.;
Malley, Karen G.;
Ishak, K. Jack;
Hietpas, Ryan T.;
García‐Pérez, Luis‐Emilio

Publication type:

Article

Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States.

Published in:

Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1299, doi. 10.1111/dom.13649

By:

Boye, Kristina S.;
Mody, Reema;
Karanikas, Chrisanthi A.;
Riesmeyer, Jeffrey S.;
Lakshmanan, Mark C.;
Riddle, Matthew C.;
Gerstein, Hertzel C.;
Garcia‐Perez, Luis‐Emilio;
Lage, Maureen J.

Publication type:

Article

Diabetes in Japan: a review of disease burden and approaches to treatment.

Published in:

Diabetes/Metabolism Research & Reviews, 2009, v. 25, n. 8, p. 705, doi. 10.1002/dmrr.1012

By:

Neville, Susan E.;
Boye, Kristina S.;
Montgomery, William S.;
Iwamoto, Kazuya;
Okamura, Masato;
Hayes, Risa P.

Publication type:

Article

Validity and analysis of the Diabetes Injection Device Preference Questionnaire (DID-PQ).

Published in:

Journal of Patient-Reported Outcomes, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41687-020-00266-x

By:

Boye, Kristina S.;
Matza, Louis S.;
Currie, Brooke M.;
Coyne, Karin S.

Publication type:

Article

EQ-5D: a plea for accurate nomenclature.

Published in:

2020

By:

Brooks, Richard;
Boye, Kristina S.;
Slaap, Bernhard

Publication type:

Letter

Burden and management of chronic kidney disease in Japan: systematic review of the literature.

Published in:

International Journal of Nephrology & Renovascular Disease, 2013, v. 6, p. 1, doi. 10.2147/IJNRD.S30894

By:

Travers, Karin;
Martin, Amber;
Khankhel, Zarmina;
Boye, Kristina S.;
Lee, Lauren J.

Publication type:

Article

Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies.

Published in:

2017

By:

Shuichi Suzuki;
Tomonori Oura;
Masakazu Takeuchi;
Boye, Kristina S.;
Suzuki, Shuichi;
Oura, Tomonori;
Takeuchi, Masakazu

Publication type:

journal article

A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes.

Published in:

2015

By:

Matza, Louis S.;
Boye, Kristina S.;
Stewart, Katie D.;
Curtis, Bradley H.;
Reaney, Matthew;
Landrian, Amanda S.

Publication type:

journal article

Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes.

Published in:

Quality of Life Research, 2021, v. 30, n. 7, p. 2033, doi. 10.1007/s11136-021-02808-2

By:

Matza, Louis S.;
Cutts, Katelyn N.;
Stewart, Katie D.;
Norrbacka, Kirsi;
García-Pérez, Luis-Emilio;
Boye, Kristina S.

Publication type:

Article

Utilities and disutilities for type 2 diabetes treatment-related attributes.

Published in:

2007

By:

Matza, Louis S.;
Boye, Kristina S.;
Yurgin, Nicole;
Brewster-Jordan, Jessica;
Mannix, Sally;
Shorr, Jodi M.;
Barber, Beth L.

Publication type:

journal article

Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes.

Published in:

ClinicoEconomics & Outcomes Research, 2016, v. 8, p. 559, doi. 10.2147/CEOR.S114699

By:

Smith-Palmer, Jayne;
Bae, Jay P.;
Boye, Kristina S.;
Norrbacka, Kirsi;
Hunt, Barnaby;
Valentine, William J.

Publication type:

Article

Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK.

Published in:

Drugs in R&D, 2019, v. 19, n. 2, p. 213, doi. 10.1007/s40268-019-0273-0

By:

Boye, Kristina S.;
Stein, Dara;
Matza, Louis S.;
Jordan, Jessica;
Yu, Ren;
Norrbacka, Kirsi;
Hassan, Syed Wasi;
García-Pérez, Luis-Emilio

Publication type:

Article

Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 Diabetes.

Published in:

Patient, 2022, v. 15, n. 3, p. 367, doi. 10.1007/s40271-022-00578-8

By:

Matza, Louis S.;
Stewart, Katie D.;
Landó, Laura Fernández;
Patel, Hiren;
Boye, Kristina S.

Publication type:

Article

Challenges to time trade-off utility assessment methods: when should you consider alternative approaches?

Published in:

Expert Review of Pharmacoeconomics & Outcomes Research, 2014, v. 14, n. 3, p. 437, doi. 10.1586/14737167.2014.912562

By:

Boye, Kristina S;
Matza, Louis S;
Feeny, David H;
Johnston, Joseph A;
Bowman, Lee;
Jordan, Jessica B

Publication type:

Article

Impact of dose frequency on compliance and health outcomes: a literature review (1966-2006).

Published in:

Expert Review of Pharmacoeconomics & Outcomes Research, 2007, v. 7, n. 2, p. 187, doi. 10.1586/14737167.7.2.187

By:

Lizheng Shi;
Hodges, Meredith;
Yurgin, Nicole;
Boye, Kristina S.

Publication type:

Article

The relationship between HbA1c reduction and healthcare costs among patients with type 2 diabetes: evidence from a U.S. claims database.

Published in:

Current Medical Research & Opinion, 2020, v. 36, n. 9, p. 1441, doi. 10.1080/03007995.2020.1787971

By:

Lage, Maureen J.;
Boye, Kristina S.

Publication type:

Article

Patient perceptions of injection devices used with dulaglutide and liraglutide for treatment of type 2 diabetes.

Published in:

2018

By:

Matza, Louis S.;
Boye, Kristina S.;
Currie, Brooke M.;
Paczkowski, Rosirene;
Lando, Laura F.;
Mody, Reema;
Jordan, Jessica

Publication type:

journal article

Physician perceptions of GLP-1 receptor agonists in the UK.

Published in:

2016

By:

Matza, Louis S.;
Curtis, Sarah E.;
Jordan, Jessica B.;
Adetunji, Omolara;
Martin, Sherry A.;
Boye, Kristina S.

Publication type:

journal article

A model of mild hypoglycemia.

Published in:

Current Medical Research & Opinion, 2015, v. 31, n. 4, p. 633, doi. 10.1185/03007995.2015.1020363

By:

Samuel, Stuart;
Goswami, Devesh;
Shum, Kenny;
Boye, Kristina S.;
Rengarajan, Badri;
Curtis, Bradley;
Curtis, Sarah E.

Publication type:

Article

Treatment approach and HbA1ccontrol among US adults with type 2 diabetes: NHANES 1999–2004.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 7, p. 1605, doi. 10.1185/03007990902973300

By:

Allison Hedley Dodd;
Margaret S. Colby;
Kristina S. Boye;
Cheryl Fahlman;
Sunny Kim;
Ronette R. Briefel

Publication type:

Article

Comparing clinical and economic characteristics between commercially-insured patients with diabetic neuropathy and demographically-matched diabetic controls.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 3, p. 585, doi. 10.1185/03007990802706289

By:

Yang Zhao;
Wenyu Ye;
Trong K. Le;
Kristina S. Boye;
John H. Holcombe;
Ralph Swindle

Publication type:

Article

Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change.

Published in:

Current Medical Research & Opinion, 2007, v. 23, n. 9, p. 2051, doi. 10.1185/030079907X219454

By:

Louis S. Matza;
Nicole Yurgin;
Kristina S. Boye;
Karen Malley;
Jodi M. Shorr

Publication type:

Article

Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.

Published in:

2007

By:

Ray JA;
Boye KS;
Yurgin N;
Valentine WJ;
Roze S;
McKendrick J;
Tucker DMD;
Foos V;
Palmer AJ;
Ray, Joshua A;
Boye, Kristina S;
Yurgin, Nicole;
Valentine, William J;
Roze, Stéphane;
McKendrick, Jan;
Tucker, Daniel M D;
Foos, Volker;
Palmer, Andrew J

Publication type:

journal article

Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.

Published in:

Current Medical Research & Opinion, 2007, v. 23, n. 3, p. 609, doi. 10.1185/030079907X178685

By:

Joshua A. Ray;
Kristina S. Boye;
Nicole Yurgin;
William J. Valentine;
Stéphane Roze;
Jan McKendrick;
Daniel M. D. Tucker;
Volker Foos;
Andrew J. Palmer

Publication type:

Article

The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes.

Published in:

Patient Preference & Adherence, 2023, v. 17, p. 793, doi. 10.2147/PPA.S401465

By:

Gelhorn, Heather L;
Osumili, Beatrice;
Brown, Katelyn;
Ross, Melissa M;
Schulz, Andrea;
Fernandez, Gabriela;
Boye, Kristina S

Publication type:

Article

Treatment-Related Attributes of Diabetes Therapies and How People with Type 2 Diabetes Report Their Impact on Indicators of Medication-Taking Behaviors.

Published in:

Patient Preference & Adherence, 2022, v. 16, p. 1919, doi. 10.2147/PPA.S367046

By:

Sims, Tracy J;
Boye, Kristina S;
Robinson, Susan;
Kennedy-Martin, Tessa

Publication type:

Article

The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study.

Published in:

Patient Preference & Adherence, 2022, v. 16, p. 1897, doi. 10.2147/PPA.S366966

By:

Gelhorn, Heather L;
Ross, Melissa M;
Shinde, Shraddha;
Thieu, Vivian Thuyanh;
Boye, Kristina S

Publication type:

Article

Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative Review.

Published in:

Patient Preference & Adherence, 2022, v. 16, p. 23, doi. 10.2147/PPA.S328583

By:

Boye, Kristina S;
Shinde, Shraddha;
Kennedy-Martin, Tessa;
Robinson, Susan;
Thieu, Vivian T

Publication type:

Article

Patient-Reported Outcomes and Impact of Type 2 Diabetes: A Cross-Sectional Study in the Kingdom of Saudi Arabia.

Published in:

Patient Preference & Adherence, 2020, v. 14, p. 2231, doi. 10.2147/PPA.S265126

By:

Gelhorn, Heather L;
Boye, Kristina S;
Shalhoub, Huda;
Matza, Louis S;
Jordan, Jessica B;
Alhammad, Ali;
Anand, Savita B;
Ekhzaimy, Aishah A;
Strizek, Alena

Publication type:

Article

Patient preferences for glucagon-like peptide 1 receptor-agonist treatment attributes.

Published in:

Patient Preference & Adherence, 2019, v. 13, p. 561, doi. 10.2147/PPA.S187907

By:

Thieu, Vivian T.;
Robinson, Susan;
Kennedy-Martin, Tessa;
Boye, Kristina S.;
Garcia-Perez, Luis-Emilio

Publication type:

Article

Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.

Published in:

Patient Preference & Adherence, 2018, v. 12, p. 971, doi. 10.2147/PPA.S159620

By:

Matza, Louis S;
Boye, Kristina S;
Jordan, Jessica B;
Norrbacka, Kirsi;
Gentilella, Raffaella;
Tiebout, Amara R;
Browne, Chantelle;
Federici, Marco Orsini;
Biricolti, Giovanni;
Stewart, Katie D

Publication type:

Article

Cost of medication adherence and persistence in type 2 diabetes mellitus: a literature review.

Published in:

Patient Preference & Adherence, 2017, v. 11, p. 1103, doi. 10.2147/PPA.S136639

By:

Kennedy-Martin, Tessa;
Boye, Kristina S.;
Xiaomei Peng

Publication type:

Article

Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan.

Published in:

Patient Preference & Adherence, 2016, v. 10, p. 1337, doi. 10.2147/PPA.S109289

By:

Gelhorn, Heather L.;
Bacci, Elizabeth D.;
Jiat Ling Poon;
Boye, Kristina S.;
Suzuki, Shuichi;
Babineaux, Steven M.

Publication type:

Article

Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK.

Published in:

Patient Preference & Adherence, 2015, v. 9, p. 1611, doi. 10.2147/PPA.S90842

By:

Gelhorn, Heather L.;
Jiat-Ling Poon;
Davies, Evan W.;
Paczkowski, Rosirene;
Curtis, Sarah E.;
Boye, Kristina S.

Publication type:

Article

Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes.

Published in:

2017

By:

Matza, Louis S.;
Boye, Kristina S.;
Stewart, Katie D.;
Davies, Evan W.;
Paczkowski, Rosirene

Publication type:

journal article

Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis.

Published in:

Diabetes Therapy, 2024, v. 15, n. 6, p. 1435, doi. 10.1007/s13300-024-01583-w

By:

Newson, Rachel S.;
Divino, Victoria;
Boye, Kristina S.;
Chen, Justin;
DeKoven, Mitch;
Vallarino, Carlos;
Ranta, Kari;
Mount, Julie E.

Publication type:

Article

An Economic Evaluation of the Relationship Between Glycemic Control and Total Healthcare Costs for Adults with Type 2 Diabetes: Retrospective Cohort Study.

Published in:

Diabetes Therapy, 2024, v. 15, n. 2, p. 395, doi. 10.1007/s13300-023-01507-0

By:

Boye, Kristina S.;
Bae, Jay P.;
Thieu, Vivian T.;
Lage, Maureen J.

Publication type:

Article

Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States.

Published in:

Diabetes Therapy, 2024, v. 15, n. 2, p. 381, doi. 10.1007/s13300-023-01499-x

By:

Boye, Kristina S.;
Jordan, Jessica B.;
Malik, Raleigh;
Matza, Louis S.

Publication type:

Article

Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide.

Published in:

Diabetes Therapy, 2023, v. 14, n. 11, p. 1867, doi. 10.1007/s13300-023-01457-7

By:

Boye, Kristina S.;
Sapin, Hélène;
Dong, Wenxiu;
Williamson, Suzanne;
Lee, Clare J.;
Thieu, Vivian Thuyanh

Publication type:

Article